Full Text View
Tabular View
No Study Results Posted
Related Studies
Study the Effects of Different Doses of UK-369,003 in Men With Lower Urinary Tract Symptoms.
This study has been completed.
Study NCT00457457   Information provided by Pfizer

First Received on April 5, 2007.   Last Updated on October 27, 2010   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Prostatic Hyperplasia
Additional conditions recognized in this trial
Erectile Dysfunction
Hyperplasia
More general conditions related to this trial
Genital Diseases, Male
Mental Disorders
Pathologic Processes
Prostatic Diseases
Sexual and Gender Disorders
Sexual Dysfunction, Physiological
Sexual Dysfunctions, Psychological
Interventions listed in this trial
Tamsulosin
UK-369,003
More general drug interventions related to this trial
Adrenergic Agents
Adrenergic alpha-1 Receptor Antagonists
Adrenergic alpha-Antagonists
Adrenergic Antagonists
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Pharmacologic Actions
Physiological Effects of Drugs
Sponsors listed in this trial
Pfizer


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services